May 22nd, 2009 – Budapest, Hungary, London, UK, Princeton, US – On April 24 ThalesNano Zrt. was honoured to receive the Millennium Award, established by the Hungarian Patent Office. The Board of Trustees, appointed by the Hungarian Patent Office, awards this accolade to institutions that play an especially important role in the protection of intellectual property.
The award was accepted by Dr. Ferenc Darvas, the Founder & Chairman. “Disruptive innovation in R&D is a integral part of the company’s accomplishments, both in the past and in the future”, said Dr. Darvas. “This award belongs to and recognizes the achivements of the entire research and development community at ThalesNano. Our corporate philosophy is to undertake our research and development with a high level of innovation that solves difficult customer problems. This is a key component in our company’s ability to develop and prosper. An integral component is the appropriate protection of intellectual property. Thanks to ThalesNano’s innovations and patents, we increased our revenue by 50 percent last year. We are very proud that we are an important supplier for nearly all of the major pharmaceutical and chemical companies worldwide including 20 out of the 20 of the world’s largest pharmaceutical companies”.
About ThalesNano Inc.
ThalesNano www.thalesnano.com is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube® continuous-flow hydrogenation reactor and the pilot plant scale version H-Cube Mid™ are used in hundreds of laboratories in four continents and have become the new industry standard for hydrogenation.
Contact: Laszlo Urge, Ph.D., CEO, e-mail: ceodirect@thalesnano.com, Telephone: +36-1-880-8500
